Search | Science Publications

Research ArticleOpen accessIn the keywordsInfluence of Process Conditions on Measles Virus StabilityK. Weiss, D. Salzig, J. Gerstenberger et al.Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied in cancer therapy. Contrary to their use as vaccine where 103 infectious virus particles per dose are needed, for cancer therapy 109 virus particles should be provided per dose. This leads to other challenges for the production process when compared to vaccine production. This study … …American Journal of Biochemistry and Biotechnology, Vol. 9, Issue 3 · 21 Sep 2013 · 9,949 accessesView PDF Cite

1 result for “Oncolytic Agent”